Latest Asx News

Memphasys has rapidly established a foothold in the UK IVF market, securing four active commercial trials and initial orders for its Felix™ sperm selection system within weeks of launch. This momentum aligns with its global expansion strategy targeting major fertility markets.

Australian Rare Earths (ASX: AR3) has announced a maiden Ore Reserve of 26 million tonnes at 920 ppm TREO for its Koppamurra Rare Earths Project, underpinned by a robust Pre-Feasibility Study delivering an A$858 million post-tax NPV and a rapid payback of less than one year.

SunRice reported a 4% rise in net profit after tax for FY26 to $73.3 million, maintaining an 8% EBITDA margin despite a 2.5% revenue decline. The company declared a record fully franked dividend of 70 cents per share but expects FY27 profit to fall amid a smaller Australian rice crop.

Renascor Resources has identified extensive copper mineralisation across multiple prospects at its Flat Hill project in South Australia, prompting a strategic program of re-assays and geophysical surveys to unlock a district-scale system.

Magellan Investment Partners has announced final distribution amounts for four of its funds ending 30 June 2026, with key dates set for early July and a Distribution Reinvestment Plan available to investors.

Cullen Resources’ Northern Finland joint venture with Capella Minerals has delivered promising copper-silver mineralization in maiden drilling at Killero E, setting the stage for upcoming gold-focused drilling at Killero W.

Corporate Travel Management (ASX:CTD) has pushed back its FY25 and 1HFY26 financial statements to August 2026 due to intertwined UK customer remediation, financing negotiations, and audit complexities, while signalling significant goodwill impairments across multiple regions.

Cyprium Metals has marked a significant milestone with the first sulphuric acid delivery to its Nifty Copper Complex in 20 years, signaling a shift from construction to commissioning. The Phase 1 Copper Cathode Restart project is advancing rapidly, with key infrastructure and operational systems nearing completion.

Theta Gold Mines (ASX: TGM) reports substantial progress on its TGME Gold Project, with major construction activities well underway and critical equipment nearing delivery, reinforcing its path to production in 2027.

Paladin Energy has identified a fresh high-grade uranium deposit named Atlas at its Patterson Lake South project in Canada, expanding its resource potential with promising drill results.

GTN Limited projects a sharp fall in FY26 earnings amid tough market conditions but signals a hefty dividend and a rebound in FY27 EBITDA.

Imagion Biosystems has raised $3.75 million to fund the start of its Phase 1b/2 clinical trial for the MagSense HER2 imaging agent in the US, following FDA clearance. The capital raising involves a two-tranche share placement with free attaching options, led by CPS Capital.